Key Factors That Influence Complex Regional Pain Syndrome Settlements

Complex regional pain syndrome (CRPS) is a chronic pain condition that often arises after injury or surgery, and its subjective nature makes settlement negotiations in personal injury or medical malpractice cases uniquely challenging. Insurers, plaintiffs, and defense attorneys weigh a mix of medical evidence, legal precedents, and policy limits to reach compensation. Below we examine recent trends, the underlying background, common user concerns, likely impact on future cases, and what to watch next.

Recent Trends

In the past several years, settlement dynamics for CRPS claims have shifted as courts and insurers gain more familiarity with the diagnosis. Key developments include:

• Greater reliance on objective testing: Thermography, quantitative sensory testing, and triple-phase bone scans are increasingly used to corroborate CRPS symptoms, influencing settlement ranges.
• Higher policy limits in severe cases: When CRPS results in permanent disability or spread to multiple limbs, settlements have trended upward, often between the mid-six figures and low seven figures in the U.S.
• More scrutiny of causation: Defense counsel now routinely challenge whether a specific accident or procedure caused CRPS, especially if there is a history of prior injury or psychological comorbidity.
• Increased use of structured settlements: To manage the long-term cost of care, some parties agree to periodic payments rather than lump sums.

Background

Complex regional pain syndrome is classified into two types: CRPS-I (formerly reflex sympathetic dystrophy) without confirmed nerve injury, and CRPS-II (causalgia) with documented nerve damage. The diagnosis remains clinical, based on the Budapest criteria (2012). Settlement value depends on several foundational factors:

• Severity and duration: Temporary mild CRPS that resolves within months yields much lower settlements than chronic, treatment-resistant cases.
• Medical expenses: Past and future costs for physical therapy, nerve blocks, spinal cord stimulators, and medications can dominate settlement calculations.
• Lost earnings: Many CRPS patients cannot return to physically demanding jobs; loss of earning capacity substantially raises damages.
• Insurance policy limits: Regardless of damages, the defendant’s available coverage acts as a ceiling. In cases with deep-pocket corporate defendants, higher limits allow for larger settlements.
• Contributory or comparative fault: If the plaintiff’s own actions contributed to the injury, settlement amounts may be reduced proportionally depending on state law.

User Concerns

Patients and their families often raise common questions when evaluating settlement offers. The most frequent worries include:

• Proving CRPS exists: Without a definitive lab test, claimants worry about credibility. Attorneys typically advise gathering consistent physician documentation and avoiding gaps in treatment.
• Inadequate compensation for pain and suffering: CRPS can cause severe allodynia, sleep disruption, and depression. General damages (non-economic) are often a point of contention, as they vary widely by jurisdiction and insurer.
• Length of litigation: CRPS cases may take one to three years to settle, especially if liability is disputed or the medical record requires expert review. Interim financial strain is a major concern.
• Risk of lien repayments: Health insurers or workers’ compensation carriers may assert liens on any settlement, reducing the net amount received by the claimant.

Likely Impact

The settlement landscape for CRPS will likely continue to evolve in several directions:

• Increased use of independent medical exams (IMEs): Carriers will more frequently require IMEs from specialists who are skeptical of CRPS, potentially driving down settlement offers for less documented cases.
• Broader acceptance of CRPS as a legitimate condition: Awareness campaigns and medical consensus documents are reducing outright denial of the diagnosis, which may strengthen plaintiffs’ positions.
• Pressure for legislative caps: Some states (e.g., California, Texas) have caps on non-economic damages in medical malpractice or personal injury cases; these caps directly affect CRPS settlement ceilings.
• More nuanced valuation models: Settlement calculators are beginning to incorporate factors like spinal cord stimulator success rates and opioid dependency risks.

What to Watch Next

Over the next twelve to eighteen months, stakeholders should monitor:

• Appellate rulings on causation standards: Several state supreme courts are expected to issue decisions regarding the admissibility of expert testimony on CRPS, which could tighten or loosen proof requirements.
• Updates to diagnostic and treatment guidelines: The International Association for the Study of Pain (IASP) periodically revises criteria; any changes will directly affect how insurers view a claim’s strength.
• Trends in jury verdicts: Even though settlements are private, published verdicts for CRPS cases (when they go to trial) signal what defendants might be willing to pay to avoid a similar outcome.
• Healthcare reimbursement policies: If major insurers reduce coverage for certain CRPS treatments (e.g., ketamine infusions), future damages calculations will need to account for out-of-pocket costs.